In the BioHarmony Drug Report Database

"Preview" Icon

Clemastine

Tavist (clemastine) is a small molecule pharmaceutical. Clemastine was first approved as Tavist on 1982-01-01. It is used to treat allergic rhinitis perennial, angioedema, and urticaria in the USA. The pharmaceutical is active against histamine H1 receptor. In addition, it is known to target P2X purinoceptor 7.

 

Trade Name

 

Tavist
 

Common Name

 

clemastine
 

ChEMBL ID

 

CHEMBL1626
 

Indication

 

allergic rhinitis perennial, angioedema, urticaria
 

Drug Class

 

Antihistaminics (histamine-H1 receptor antagonists)

Image (chem structure or protein)

Clemastine structure rendering